José Mario Sabio1, Josefina Martinez-Bordonado2, Isabel Sánchez-Berná2, José Antonio Vargas-Hitos2, Juan Diego Mediavilla2, Nuria Navarrete-Navarrete2, Mónica Zamora-Pasadas2, Manuela Expósito Ruíz2, Juan Jiménez-Alonso2. 1. From the Systemic Autoimmune Diseases Unit, Department of Internal Medicine, and Hypertension and Lipids Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; Department of Statistics, Investigación Biosanitaria de Andalucía Oriental Foundation, Granada, Spain.J.M. Sabio, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J. Martinez-Bordonado, MD, Research Fellow, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; I. Sánchez-Berná, MD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J.A. Vargas-Hitos, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J.D. Mediavilla, MD, PhD, Hypertension and Lipids Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; N. Navarrete-Navarrete, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; M. Zamora-Pasadas, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; M.E. Ruíz, MD, Department of Statistics, Investigación Biosanitaria de Andalucía Oriental Foundation; J. Jiménez-Alonso, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves. jomasabio@gmail.com. 2. From the Systemic Autoimmune Diseases Unit, Department of Internal Medicine, and Hypertension and Lipids Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; Department of Statistics, Investigación Biosanitaria de Andalucía Oriental Foundation, Granada, Spain.J.M. Sabio, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J. Martinez-Bordonado, MD, Research Fellow, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; I. Sánchez-Berná, MD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J.A. Vargas-Hitos, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; J.D. Mediavilla, MD, PhD, Hypertension and Lipids Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; N. Navarrete-Navarrete, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; M. Zamora-Pasadas, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves; M.E. Ruíz, MD, Department of Statistics, Investigación Biosanitaria de Andalucía Oriental Foundation; J. Jiménez-Alonso, MD, PhD, Systemic Autoimmune Diseases Unit, Department of Internal Medicine, University Hospital Virgen de las Nieves.
Abstract
OBJECTIVE: To compare 24-h ambulatory blood pressure (BP) monitoring (ABPM) values and patterns in women with systemic lupus erythematosus (SLE) with those of a matched control group and their relationship with the presence of subclinical atherosclerosis. METHODS: ABPM was assessed in 70 women with SLE and in 65 sex- and age-matched controls without a history of clinic cardiovascular disease (CVD). Carotid-femoral pulse wave velocity (PWV), which is a marker of subclinical atherosclerosis and a predictor of future CVD, was measured. Multivariate logistic analysis was used to determine which explanatory variables were independently associated with the non-dipper pattern and the presence of nocturnal hypertension (HTN) in women with SLE. RESULTS: No differences in PWV were found between patients and controls [median 7.3, interquartile range (IQR) 6.5-8.1 m/s vs median 7.1, IQR 6.5-7.8 m/s, p = 0.474]. The frequency of nondipper pattern (p = 0.025) and nocturnal HTN (p = 0.004) was significantly higher in women with SLE than in controls. White-coat and masked HTN were present in 10% and 11% of patients and in 20% and 8% of controls, respectively (p > 0.05 in all cases). The concordance between office and ambulatory HTN in the SLE and control groups was modest (κ = 0.325 and κ = 0.451, respectively). PWV and chronic kidney disease, and PWV and the Systemic Lupus Erythematosus Disease Activity Index were found to be independently associated with nocturnal HTN and nondipper pattern, respectively. CONCLUSION: Women with SLE were more likely to have an altered nighttime BP pattern than controls. In women with SLE, nondipper pattern and nocturnal HTN were independently associated with increased subclinical atherosclerosis measured by PWV.
OBJECTIVE: To compare 24-h ambulatory blood pressure (BP) monitoring (ABPM) values and patterns in women with systemic lupus erythematosus (SLE) with those of a matched control group and their relationship with the presence of subclinical atherosclerosis. METHODS: ABPM was assessed in 70 women with SLE and in 65 sex- and age-matched controls without a history of clinic cardiovascular disease (CVD). Carotid-femoral pulse wave velocity (PWV), which is a marker of subclinical atherosclerosis and a predictor of future CVD, was measured. Multivariate logistic analysis was used to determine which explanatory variables were independently associated with the non-dipper pattern and the presence of nocturnal hypertension (HTN) in women with SLE. RESULTS: No differences in PWV were found between patients and controls [median 7.3, interquartile range (IQR) 6.5-8.1 m/s vs median 7.1, IQR 6.5-7.8 m/s, p = 0.474]. The frequency of nondipper pattern (p = 0.025) and nocturnal HTN (p = 0.004) was significantly higher in women with SLE than in controls. White-coat and masked HTN were present in 10% and 11% of patients and in 20% and 8% of controls, respectively (p > 0.05 in all cases). The concordance between office and ambulatory HTN in the SLE and control groups was modest (κ = 0.325 and κ = 0.451, respectively). PWV and chronic kidney disease, and PWV and the Systemic Lupus Erythematosus Disease Activity Index were found to be independently associated with nocturnal HTN and nondipper pattern, respectively. CONCLUSION:Women with SLE were more likely to have an altered nighttime BP pattern than controls. In women with SLE, nondipper pattern and nocturnal HTN were independently associated with increased subclinical atherosclerosis measured by PWV.
Authors: Daniel A Carranza-Leon; Annette Oeser; Qiong Wu; C Michael Stein; Michelle J Ormseth; Cecilia P Chung Journal: Lupus Date: 2020-08-25 Impact factor: 2.911
Authors: Marta Toral; Rosario Jiménez; Miguel Romero; Iñaki Robles-Vera; Manuel Sánchez; Mercedes Salaices; José Mario Sabio; Juan Duarte Journal: Arthritis Res Ther Date: 2017-12-06 Impact factor: 5.606
Authors: Mónica Vázquez-Del Mercado; Felipe de J Perez-Vazquez; Eduardo Gomez-Bañuelos; Efrain Chavarria-Avila; Arcelia Llamas-García; Karla I Arrona-Rios; Gustavo Ignacio Diaz-Rubio; Sergio Durán-Barragán; Rosa E Navarro-Hernández; Bethel P Jordán-Estrada; Natalia Prado-Bachega; Miguel A A Gonzalez-Beltran; Carlos Ramos-Becerra; Fernando Grover-Paez; David Cardona-Müller; Ernesto G Cardona-Muñoz Journal: PLoS One Date: 2018-12-05 Impact factor: 3.240
Authors: Adam R Poliwczak; Katarzyna Dworniak; Elżbieta Waszczykowska; Robert Irzmański Journal: Postepy Dermatol Alergol Date: 2022-07-14 Impact factor: 1.664